Tibulizumab
Tibulizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tibulizumab is under investigation in clinical trial NCT03736772 (A Study of LY3090106 in Japanese and Caucasian Healthy Participants).
| Trade Name | Tibulizumab |
| Generic | Tibulizumab |
| Tibulizumab Other Names | Tibulizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tibulizumab
